MNOW — Mednow Cashflow Statement
0.000.00%
Last trade - 00:00Consumer DefensivesSpeculativeMicro Cap
Annual cashflow statement for Mednow, fiscal year end - July 31st, CAD millions except per share, conversion factor applied.
2018 July 31st | 2019 July 31st | 2020 July 31st | 2021 July 31st | 2022 July 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.007 | -0.012 | -0.469 | -8.95 | -29.6 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | — | — | — | 3.38 | 11.7 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.001 | 0.003 | 0.036 | -0.215 | 0.661 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -0.005 | -0.009 | -0.433 | -5.59 | -16.1 |
| Capital Expenditures | 0 | -0.118 | -0.099 | -1.01 | -3.06 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | — | -2.57 | -4.98 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | -0.118 | -0.099 | -3.58 | -8.04 |
| Financing Cash Flow Items | 0.005 | 0.127 | -0.087 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.005 | 0.127 | 5.79 | 32.7 | 0.339 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0 | 0 | 5.26 | 23.5 | -23.8 |